“There’s Biolife Sciences, which rose as high as 41,800% in less than a year…A small, $1,000 stake could have brought back as much as $418,000.” It’s the tip of the iceberg of a $3.2 trillion breakthrough that I believe will change the way we look at medicine.”īy subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff believes it will change the world of medicine.Īs part of the new promotion, The Near Future Report dazzles investors with stories of making huge returns by investing in the right biotech or medical technology companies. “But there’s more to this technology than just saving my life. Instead, he claims this company is just the tip of the iceberg of a $3.2 trillion industry that will change the world of medicine: Jeff doesn’t just recommend investing in this company to capitalize on this trend. And gave me a fighting chance to beat it super early - before it grew into a potentially deadly problem.” “…it’s an incredible new trend in medicine - driven by technology - that spotted cancer. One guide focuses on a company making treatments for cystic fibrosis, for example, another precision medicine stock Jeff describes as the “king of genetic sequencing.”īecause of Jeff’s personal experience with this medical technology, he believes it can change the world: Several of those guides focus on medical technology, including the technology created by this company. That company has a technology that performs a complete scan of your body, delivering unprecedented insights into your health.īy subscribing to The Near Future Report today, you get a bundle of bonus reports and investment guides. To visit a company whose groundbreaking technology is changing the medical industry.” That’s why I traveled thousands of miles to a small office in California. “…as an angel investor in Silicon Valley… I get to see all kinds of new technologies – before the rest of the market hears about them. Jeff claims this company is developing “groundbreaking technology” that will change the medical industry. Through his angel investing work, however, Jeff learned about a medical technology company based in California.

The bleeding edge jeff brown review